AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Navigating Relapsed CLL Treatment Options
This chapter examines treatment strategies for relapsed or refractory chronic lymphocytic leukemia (CLL), focusing on fixed-duration and indefinite therapies involving key medications like obinutuzumab and venetoclax. It follows a patient case to illustrate the need for careful management and evaluation amidst complications such as tumor lysis syndrome and new anemia. The discussion further emphasizes the evolving landscape of second-line therapies, including the role of BTK inhibitors and the potential for allogeneic transplants.